Q9976 – Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
HCPCS Level II code · Q codes: Temporary Codes
HCPCS codeQ9976
- Long description
- Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
- Short description
- Inj ferric pyrophosphate cit
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Cross reference
- J1443
- Added
- July 1, 2015
- Last change
- January 1, 2016 – No change
- Termination date
- December 31, 2015
Frequently asked questions
What is HCPCS code Q9976?
Q9976 is a HCPCS Level II code for injection, ferric pyrophosphate citrate solution, 0.1 mg of iron. It was discontinued on December 31, 2015.
Does Medicare cover Q9976?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby Q codes
- Q9967 – Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
- Q9968 – Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
- Q9969 – Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
- Q9970 – Injection, ferric carboxymaltose, 1mg
- Q9972 – Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- Q9973 – Injection, epoetin beta, 1 microgram, (non-esrd use)
- Q9974 – Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
- Q9975 – Injection, factor viii fc fusion protein (recombinant), per iu
- Q9977 – Compounded drug, not otherwise classified
- Q9978 – Netupitant 300 mg and palonosetron 0.5 mg
- Q9979 – Injection, alemtuzumab, 1 mg
- Q9980 – Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
- Q9981 – Rolapitant, oral, 1 mg
- Q9982 – Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- Q9983 – Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- Q9984 – Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.